Skip to Content

Lumoxiti Prices, Coupons and Patient Assistance Programs

Lumoxiti (moxetumomab pasudotox) is a member of the miscellaneous antineoplastics drug class and is commonly used for Hairy Cell Leukemia.

Lumoxiti Prices

The cost for Lumoxiti intravenous powder for injection 1 mg is around $2,217 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Lumoxiti price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Powder For Injection

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Lumoxiti Coupons and Rebates

Lumoxiti offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Lumoxiti Patient Savings Program: Eligible commercially insured patients may pay $0 per month with savings of up to $26,000 per year; for additional information contact the program at 844-694-6628.

Applies to:
Lumoxiti
Number of uses:
per prescription per year

More information please phone: 844-694-6628 Visit Website

Patient Assistance Programs for Lumoxiti

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Lumoxiti (moxetumomab pasudotox-tdfk) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Access 360

Elligibility requirements:
  1. Determined case by case
  2. Varies. *See below for details
  3. Not specified
  4. The patient must also be a US resident, green card or work visa holder.
  5. Contact program for more details: www.myaccess360.com
Applicable drugs:
  • Lumoxiti (moxetumomab pasudotox-tdfk) Injection; IV

More information please phone: 844-275-2360 Visit Website

Provider: InnateCares

Elligibility requirements:
  1. Determined case by case
  2. Varies
  3. Medically Necessary as determined by a Doctor
  4. Must be residing in the US or Puerto Rico
  5. Co-payment and patient support available for eligible patients.
Applicable drugs:
  • Lumoxiti (moxetumomab pasudotox-tdfk) Injection; IV

More information please phone: 844-694-6628 Visit Website